Semi-mechanistic efficacy model for PARP + ATR inhibitors-application to rucaparib and talazoparib in combination with gartisertib in breast cancer PDXs. [PDF]
Villette CC +9 more
europepmc +1 more source
Gender gap in medicine: a call to action for Latin America. [PDF]
Negrotto L +12 more
europepmc +1 more source
A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250). [PDF]
Navarro A +18 more
europepmc +1 more source
Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy. [PDF]
Ivanyi P +9 more
europepmc +1 more source
Health outcomes and healthcare service use in older adults with and without multiple sclerosis: a plain language summary. [PDF]
Freeman L +5 more
europepmc +1 more source
Interdisciplinary Nanomaterials for Biomedical Imaging and Sensing Applications. [PDF]
Chen X, Fung AH, Luka G, Fung AA.
europepmc +1 more source
"The deadly dance of alveolar macrophages and influenza virus". C. David, C. Verney, M. Si-Tahar and A. Guillon. <i>Eur Respir Rev</i> 2024; 33: 240132. [PDF]
europepmc +1 more source

